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ARTICLE
Pediatric multiple sclerosis in Venezuela 
Esclerosis múltiple pediátrica en Venezuela
Joaquín A. Peña1, María Elena Ravelo2, Evelio Rubio3, Dulce Pirela4, Arnoldo Soto3, Cecilia Montiel Nava5
Multiple sclerosis (MS) is a demyelinating disorder of the 
central nervous system and the most common disabling neu-
rological disorder in young adults1,2. It is clinically character-
ized by a variety of neurological signs and symptoms which 
are attributed to white matter lesions. Those lesions are dis-
seminated in time and space. Clinical signs may appear in 
sudden attacks or be insidious and progressive3,4. The diag-
nosis of pediatric MS has been largely overlooked by pedia-
tricians and pediatric neurologists5,6, who have long regard-
ed it as a rare disease. Recently, there is emerging evidence 
which proves that MS can manifest in childhood and adoles-
cence. In addition, the challenges in its differential diagnosis 
make the diagnosis in this age group a difficult task7. Other 
disorders, including leukodystrophies and metabolic diseas-
es, may masquerade the clinical picture of MS in pediatric pa-
tients. Furthermore, children with MS may present with clin-
ical symptoms that can hardly be distinguished from acute 
disseminated encephalomyelitis (ADEM)5,8,9.
 Several reviews of the MS epidemiology reveal prevalence 
estimates of pediatric onset MS ranging from 2.7 to 10.5% of 
all people with MS5,10. However, most studies on pediatric MS 
come from high –risk areas and little is known about this dis-
order in Latin America11. Only three retrospective studies, two 
in Brazil12,13 and one in Venezuela14, have dealt with demo-
graphics and epidemiological characteristics of children with 
MS. In Venezuela, Peña et al.14 reported on the demographics 
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ABSTRACT
Objective: To describe the epidemiological and clinical characteristics of Venezuelan pediatric patients with multiple sclerosis (MS). Methods: 
Database records from the National Program for MS were searched for patients with an established diagnosis of MS whose first symptoms 
appeared before age 18. Results: The national database held records of 1.710 patients; 3.8% had onset of the first symptoms before age 18. 
46.7% were boys, yielding an F:M ratio of 1.13:1. Many children had a disease onset characterized by motor impairment (30.7%), brainstem/
cerebellum and spinal cord affectation (27.6%), headache (26%). Less frequent symptoms were sensory symptoms (8%) and optic neuritis 
(7%). Discussion: Pediatric MS patients in Venezuela represent a significant proportion of all MS cases. The clinical pattern is characterized 
by motor symptoms at onset, and predominantly monosymptomatic presentation with a relapsing-remitting pattern. This is the first system-
atic attempt to estimate the prevalence of pediatric MS in Venezuela.
Key words: multiple sclerosis, demyelinating disorders, children, epidemiology.
RESUMEN
Objetivo: Describir las características clínicas y epidemiológicas de pacientes pediátricos venezolanos con EM. Métodos: Se revisó la base 
de datos del Programa Nacional para EM, identificando pacientes con diagnóstico establecido de EM antes de los 18 años de edad. Resul-
tados: La base de datos registró 1.710 pacientes y 3,8% tenía una edad de aparición menor de 18 años. De estes, 46,7% eran varones, dando 
una relación F:M de 1.13:1. Muchos niños tuvieron una aparición de la enfermedad caracterizada por déficit motor (30,7%), afectación del 
tronco encefálico-cerebelo y la médula espinal (27,6%), dolor de cabeza (26%). Síntomas menos frecuentes fueron sensoriales (8%) y neuritis 
óptica (7%). Discusión: Los pacientes pediátricos venezolanos con MS representan una proporción significativa de todos los casos de MS. 
El patrón clínico está caracterizado por síntomas motores y presentación predominantemente monosintomática con patrón brote-remisión. 
Este es el primer intento sistemático para estimar la prevalencia de MS pediátrica en Venezuela.
Palabras-Clave: esclerosis múltiple, trastornos desmielinizantes, niños, epidemiología.
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and clinical feature of 11 Venezuelan patients and compar-
ing them with those of 46 patients with ADEM. The results 
of this study yielded an estimated overall rate of MS about 
4.5/100,000, with 2.5% for the pediatric age. To our knowl-
edge, no other studies have been conducted in our region 
with pediatric patients.
Diagnostic and treatment services for children with MS 
have been developed in many countries10,15,16, while there is 
a significant lack of resources in others11,17. It is important to 
gather more precise information about the extent of the dis-
ease regarding demographics and its clinical course in the pe-
diatric age group. Such information will help in providing ad-
equate services for these children. The aim of this study was 
to describe the epidemiological and clinical characteristics of 
Venezuelan pediatric patients with MS.
METhodS
All Venezuelan patients with inflammatory diseases of 
the central nervous system are registered in a database of the 
National Program for Multiple Sclerosis which is administrated 
by the Venezuelan Institute of Social Security (IVSS, Caracas). 
The Venezuelan national MS registry is a comprehensive data-
base of all MS patients which includes the information about 
first clinical event, lab tests, neuroimaging and course of the 
disease. That information allows for the study of epidemiologi-
cal variables, such as demographics and clinical profile. These 
registries are implemented to facilitate the correct distribution 
of disease, modifying therapy among Venezuelan MS patients. 
These drugs are provided free of charge to every patient that 
fulfills the diagnostic criteria for MS. Database records with a 
MS history form, collected from August 1993 to August 2010, 
were searched for patients with an established diagnosis of 
MS whose first symptoms regarding a demyelinating event ap-
peared below the age of 18 years. For the purposes of this study, 
the International Pediatric MS Study Group consensus diag-
nostic criteria were used to define Pediatric MS5. 
RESULTS
By the time of the study, the complete national database 
held records of 1.710 patients diagnosed with MS. From this 
group, 65, which correspond to 3.8%, had an age of onset of 
the first symptoms consistent with a demyelinating event be-
low 18 years of age. As it is shown in Table 1, the vast major-
ity of patients belonged to the adolescent age group (n=36, 
55.5%). Symptoms onset was below 10 years of age for 13 
children (19.9%), between 10 and 14 years of age for 16 chil-
dren (24.6%), and for 36 children (55.5%) in the range of 
15-18 years. It seems that the proportion of children diagnosed 
with MS increased with age. From the total pediatric sample 
(n=65), 31 (46.7%) were boys, yielding a F:M ratio of 1.13:1 for 
the entire group, with a higher number of females in the ado-
lescent group. Regarding race and ethnicity characteristics, all 
patients were mestizos or white non-caucasians, with absence 
of native amerindian or afro american children.
As exhibited in Table 2, many children had a disease 
onset characterized by motor impairment (n=20, 30.7%), 
brainstem/cerebellum and spinal cord affectation (n=18, 
27.6%), headaches (n=17, 26%). Less frequent symptoms at 
onset were sensory symptoms (n=10, 8%) and optic neuri-
tis (n=9, 7%). Polysymptomatic presentation with encephal-
opathy was observed in 2 patients from the younger group 
(<10 years of age). One patient presented with seizures; and 
another one had a diagnosis of primary progressive MS; 
while the remainder had a diagnosis of relapsing-remitting 
MS (RRMS) (n=64, 98.4%). 
dISCUSSIoN
In the present study, the estimated prevalence of pedi-
atric onset MS in Venezuela was 3.8% of all MS cases. This 
number is very close to those previously reported in other 
countries1,3,15,16,18. We defined pediatric MS using 18 years as 
a cut point according to the consensus definitions published 
by the International Pediatric MS Study Group in 20075. 
Other studies have used variable definitions and onset be-
low 16 years, indicating that the estimated prevalence in our 
country would probably be less than that reported. However, 
Table 2. Clinical symptoms.






Optic neuritis 9 7.32
Diplopia 9 7.32
Urinary incontinence 7 5.69
Facial paralysis 6 4.88
Dysarthria 3 2.44




Table 1. Age distribution.
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our study provides an estimate of the actual prevalence of pe-
diatric onset MS in Venezuela, as the MS National Program 
received all the patients with MS diagnosis at the time of the 
study. So, we consider this as the best estimate of pediatric 
MS in our country, since we sampled the total of known cas-
es at the time of the study. Obviously, case ascertainment in 
pediatric MS represents a significant factor affecting estima-
tions of the prevalence17.
 The female to male ratio in our series was 1.13:1 for the 
entire group, being dependent on the age at the manifestation 
of the disorder. For children older than 14 years, we found a 
female predominance, which resembles the gender propor-
tions that are usually seen in adult MS. This greater number 
of females than males is one of the most consistent findings 
in the MS literature 3,15,16,18,19, which points toward a possible 
role for puberty hormonal changes that modulate the immu-
nological state10,15,19. We also observed that the prevalence of 
pediatric MS was higher in the adolescent age group, which 
is consistent with other studies. These findings might be ex-
plained by an eagerness to reach the diagnosis in older chil-
dren in comparison with the younger ones. Also, it is possi-
ble that older children might present more clinical episodes 
which helps clarify the diagnosis of MS. Most of the patients 
were mestizos and white non-caucasian, probably reflecting 
the ethnic characteristics of our country20. 
We found a high rate of motor impairment and brain-
stem/cerebellum signs at disease manifestation about 30% 
each, followed by sensory symptoms and optic neuritis 
(10%). In addition, headache was seen in about 25% of pa-
tients at onset. Boiko et al.18, in their series of 116 pediatric 
patients, reported that only 10% presented with weakness. 
Brainstem dysfunction and sensory disturbances were the 
initial presentation in about 13 and 26 % of their patients, 
respectively. In the Italian study, 25% of patients present-
ed with brainstem dysfunction; motor and sensory symp-
toms were presented by 18 of patients at onset16. An ear-
lier German nationwide study reveals that 44, 30 and 29% 
of pediatric patients displayed cerebellar signs, brainstem 
and motor signs at onset, respectively21. More recently, in a 
Brazilian study among the initial presentation, there was a 
predominance of motor impairment (38%) and brainstem/
cerebellum (22.5%)13. Therefore, our patients displayed a 
higher frequency of motor and brainstem/cerebellum signs 
than the majority of studies. However, direct comparisons 
are difficult due to the methodological differences among 
case definitions and patients ascertainment in the differ-
ent studies. Like in other reports on pediatric MS, the vast 
majority of patients presented with a relapsing-remitting 
course of the disease and only one patient had a diagnosis 
of primary progressive MS. It has been proposed by many 
authors that disease progression is slower and more de-
layed in pediatric MS patients in comparison to adult MS 
patients4. It appears that recovery after a clinical exacerba-
tion is shorter in children than in adults, and a lower pro-
portion of children are classified with progressive forms of 
the disease. 
The results of this study need to be interpreted with cau-
tion. It is possible that a prevalence rate of pediatric MS in 
Venezuela of 3.8% might be an underestimation, since the 
sample only included those patients who were receiving 
disease modifying therapy. On the other hand, using the 
national MS registry, this sample covers all the cases di-
agnosed, documented and registered in the country at the 
time of the study. In that way, we considered it as the best 
current estimation of MS prevalence and epidemiological 
data of pediatric MS in Venezuela. Furthermore, this infor-
mation adds to the scarce body of literature of pediatric MS 
in Latino children.
In conclusion, pediatric MS patients in Venezuela rep-
resent a significant proportion of all MS cases. The clini-
cal pattern is similar to the pattern reported in other parts 
of the world, which is characterized by motor symptoms at 
onset and predominantly monosymptomatic presentation 
with a relapsing-remitting pattern. This is the first system-
atic attempt to estimate the prevalence of pediatric MS in 
Venezuela. The study provides a foundation for future epide-
miological studies with larger samples and better case ascer-
tainment, and will allow establishing a better characteriza-
tion of pediatric MS patients and the identification of its risks 
and etiological factors.
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